Skip to main content
FinSpry Logo
FinSpry
NEO logo
NEO
(NASDAQ)
NeoGenomics, Inc.
$15.94-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NeoGenomics (NEO) Stock Price & Financial Analysis

NeoGenomics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$15.89 - $16.40
52-Week High$16.92
52-Week Low$5.65
Open$16.38
Volume905.85K
Average Volume (3M)2.79M
Market Cap2.09B
Shares Outstanding130.83M
Price to Sales (P/S)2.83
Price to Book (P/B)2.76
EV/EBITDA-20483.52
Revenue (TTM)766.29M
Net Income (TTM)-51.88M
Free Cash Flow (TTM)-7.36M
EPS (TTM)$-0.50
Profit Margin-6.77%
Operating Margin-8.63%
Return on Equity (ROE)-6.60%
Debt to Equity0.48
50-Day MA$13.41
200-Day MA$11.02
52-Week Change185.69%
Annual Dividend$0.00
Dividend Yield0.00%
Last Dividend Ex-DateDec 17, 2020

Frequently Asked Questions About NeoGenomics

What is the current stock price for NEO?

As of the latest trading session, NEO stock trades at $15.94. The 52-week range is $5.65–$16.92, with a day range of $15.89–$16.39.

What is the P/E ratio for NEO?

The P/E ratio (Price-to-Earnings) for NEO is shown in the Key Statistics section. This valuation metric helps compare NeoGenomics, Inc. to industry peers.

Does NEO pay dividends?

NeoGenomics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NEO?

Based on 3 analysts, the consensus for NEO is Hold.

What is the market cap of NEO?

NeoGenomics's market capitalization is $2.09B, classifying it as a mid-cap company. NeoGenomics operates in the Healthcare sector within the Diagnostics & Research industry.